...
机译:两种呼吸道合胞病毒(RSV)疫苗的安全性和免疫原性比较—高危老人同时给予不带佐剂的疫苗或加明矾的佐剂—同时给予流感疫苗
1 Department of Medicine, Rochester General Hospital, and University of Rochester School of Medicine, Rochester, New York 2 Department of Medicine, Brown University School of Medicine, Providence, Rhode Island 3 Eastern Virginia Medical School, Norfolk 4 Divisions of Infectious Diseases and International Health, University of Virginia, School of Medicine, Charlottesville, Virginia 5 St. Louis Department of Veterans Affairs Medical Center and Saint Louis University, St. Louis, Missouri 6 Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 7 Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, Connecticut 8 PATH and University of Washington School of Medicine, Seattl;
机译:两种呼吸道合胞病毒(rsv)疫苗(非佐剂疫苗或明矾佐剂疫苗)与流感疫苗同时提供给高危老年人的安全性和免疫原性比较。
机译:年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性:MF59辅助疫苗与非辅助疫苗
机译:MF59辅助流感疫苗在老年人中的安全性:意大利北部mf59辅助疫苗与非辅助流感疫苗的比较研究结果
机译:单剂量联合呼吸道合胞病毒(RSV)疫苗微粒制剂可改善免疫原性并减少斑块
机译:呼吸道合胞病毒(RSV)的恒河猴模型,用于评估DNA疫苗的免疫原性和保护功效。
机译:年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性:MF59辅助疫苗与非辅助疫苗
机译:年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性:MF59辅助疫苗与非辅助疫苗▿†